World's Safety In Hands Of A Few Biotechs; Who Cares?
This article was originally published in Scrip
Executive Summary
The safety of the US, and even the rest of the world, against biological threats – either manmade or natural – rests in the hands of a relatively small number of biopharmaceutical companies, most of which are small private firms, whose investors are reluctant to stick around if there's an unclear regulatory pathway and an uncertain market for the products those firms produce, Jim Greenwood, president and CEO of the Biotechnology Innovation Organization, told a House subcommittee on Feb. 12.